A sudden increase in drug prices by 200 to 400 percent has created a crisis for pharmacies and patients, coinciding with the Iranian President's announcement of lost drug currency quotas. The Minister of Health estimates the number of unavailable items at 300, while the head of the Pharmacists Association puts it at 100. Now, obtaining many medications requires standing in long lines for subsidized drugs or spending large amounts in the black market. The loss of drug currency quotas and price increases, which the Minister of Health refers to as 'price correction,' are not new issues, but the steep slope of these 'corrections' exacerbates the annual impact on health and medical conditions. It has now been proposed that for the year 1404, the 38,000 Toman currency will replace the preferential 4,200 Toman currency for drugs and medical equipment, a figure that will once again intensify the current crisis. Radio Farda has interviewed several stakeholders in the drug sector and patients in various cities to examine the state of drugs and the reasons for the new crisis. The names mentioned in this report are pseudonyms based on the interviewees' requests. The gradual removal of preferential currency began in 1397 when multiple exchange rates were introduced, and drugs became eligible for the 4,200 Toman preferential currency. This trend continued until November of this year. According to Eghtesad Online, this amount decreased from 3.5 billion dollars in 1397 to 1.5 billion dollars in 1400. Notably, late in 1398, with the outbreak of COVID-19, the need for drugs increased, but the allocation of preferential currency decreased. In 1401, in addition to the reduction of preferential currency, part of the imports was conducted with a 28,500 Toman exchange rate. The government's proposal in the 1404 budget bill is to allocate a 38,500 Toman currency for essential goods, a figure that has not yet been approved, but the Minister of Health has stated that next year, drugs will not have preferential currency. This change will lead to price increases. Reports indicate a collapse in drug production and the exodus of pharmacists from Iran. Mohammad Reza Zafarghandi, the Minister of Health, has attributed the current increase in drug prices to 'exchange rate fluctuations,' but allocations indicate that the government's change in stance has caused this. After his statements, several pharmaceutical companies confirmed a 200 to 400 percent increase in the prices of some drugs. There is still disagreement among officials regarding the items that are rare and unavailable. The Minister of Health has announced that there is a shortage of 300 drug items, but the head of the Pharmacists Association believes that number is 100, a significant numerical discrepancy. Special drugs are allocated to state pharmacies. These days, to obtain a prescription, one must stand in long lines at one of the pharmacies in their residential area. Most of the people waiting are aged 60-70. Narges used to buy a 30-pack of 'Vyas' - a methamphetamine compound - for 300,000 Toman, which is now unavailable; this drug in the free market costs between 1,200,000 to 350,000 Toman and is classified as a psychiatric medication. Marandi, the head of the Academy of Medical Sciences, has stated that the increase in drug prices, their shortages, and the creation of opaque markets are the result of conflicts of interest and weak oversight, all of which are under the government's control. Hami has advertised the sale of 23 vials of 'Tamlitide and Masiza' - drugs for controlling type 2 diabetes - for 23 million Toman. The same vials are sold by Houman for 1,200,000 to 300,000 Toman. These vials are Iranian and are sold by unidentified individuals instead of pharmacies. The drug situation in other cities is more critical than in Tehran. Majid, a citizen from Ahvaz, says: 'Painkillers for cancer patients are no longer available.' The issue is not the absence of drugs; various drugs, both domestic and foreign, are available in the Telegram black market at astronomical prices. Reza, a pharmacist in Yazd, does not deny the price increases but says that the increases are not noticeable compared to the shortages. 'Betamethasone' and 'Dexa' pills have become unavailable. 'Plavix' - a drug that prevents blood clots - is sold individually. Shortages include a range of heart and nerve medications, including 'Nortriptyline' and 'Tranqopin.' The head of the Academy of Medical Sciences has stated that the President has emphasized that 'next year we will not have a problem with drugs and medical equipment.' This directive language is characteristic of Ebrahim Raisi when facing problems and has been criticized by the rival faction. Reza states: 'Drugs are available in warehouses but are not distributed. For example, 'Alprazolam' was distributed a few months ago, but its production date was from the previous year, and then suddenly there was a shortage.' According to him, in such conditions, pharmacies are forced to ration their supplies to ensure that their minimum stock reaches more people. When preferential currency was allocated to drugs, the situation was not acceptable. Now, Masoud Pezeshkian, the President, has announced that 'some of the currencies we allocate for drug imports and their subsidies are lost.' The newspaper 'Javan' finds it strange to raise this issue considering Pezeshkian's managerial and executive background in the health sector, as it has been raised multiple times in recent years, with the spending locations always specified. This newspaper cites the import of dog and cat food, shovel handles, ice cream sticks, and cosmetics as examples. Hadi Ahmadi, the public relations manager of the Iranian Pharmacists Association, believes that 'drug currency is given to universities and insurance organizations, but their priority is to pay the salaries of retirees and staff and treatment centers, and if anything is left, it goes to the private sector and drugs.' Moein, a drug importer, does not deny this view but tells Radio Farda: 'In a country where oil rigs, museum carpets, and fuel are lost, the loss of currency is the most natural event.' According to him, institutions and some semi-private companies receive drug currency allocations but spend it on importing cars, cosmetics, or the 'Resistance Front.' He states: 'The receiving institutions are known, but no one is accountable. Mr. Pezeshkian also knows which institution swallows the drug currency; he just cannot name it.' He discusses the current state of the drug market, saying: 'Manufacturing units know in advance what transformations the drug sector will undergo. Therefore, after a period of abundance, they create shortages and deficits in the market to increase the buying frenzy through rationing, which means profit.' According to the public relations manager of the Pharmacists Association, since 1394, the share of drugs from GDP has decreased from eight to four. This reduction has created imbalance and inconsistency in the revenues of insurance organizations, universities, and the health system. Given their different priorities, ultimately, out-of-pocket payments by the public increase. However, the Minister of Health has stated that insurance organizations will compensate for this 'price correction.' Organizations that have previously proven themselves. According to the public relations manager of the Pharmacists Association, the Social Security Organization has not made any payments to pharmacies since July of this year. According to the law, insurance organizations must pay 60 percent of the drug cost immediately after the documents are submitted to the pharmacy. While pharmacies may not be able to confront insurance organizations, the public is the only group that must fight against the crisis of drug shortages and prices.
Drug Crisis in Iran; Lost Currency and Patients Waiting in Line
Iran is facing a severe drug crisis marked by a dramatic increase in prices and shortages of essential medications. The government has announced a shift in currency allocation for drugs, which is expected to worsen the situation. Patients are struggling to access necessary treatments, often resorting to long lines or the black market.
👥 Key Players
📰 What Happened
Iran is experiencing a drug crisis due to a sudden increase in medication prices by 200 to 400 percent and a significant shortage of essential drugs. This situation is exacerbated by the government's decision to alter drug currency quotas, leading to long lines for subsidized medications and a thriving black market.
- The Minister of Health estimates 300 unavailable drug items, while the Pharmacists Association cites 100.
- The preferential currency for drugs is set to change from 4,200 Toman to 38,500 Toman, further increasing prices.
💡 Why It Matters
📚 Background
Iran has faced economic difficulties and sanctions that have strained its healthcare system, leading to reliance on subsidized drug prices. The gradual removal of preferential currency has worsened the situation.
Translated from the original and edited for English readers. View original source →
Translation confidence: 85%